+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neurostimulation Devices Market Analysis 2019

  • ID: 4857822
  • Report
  • October 2019
  • Region: Global
  • 159 pages
  • Syngene Research
1 of 3

FEATURED COMPANIES

  • Biocontrol Medical
  • Cyberonics, Inc.
  • Medtronic, Inc.
  • Neuronetics, Inc.
  • Neuropace, Inc.
  • Neurosigma, Inc.
  • MORE
The Global Neurostimulation Devices market is expected to reach $14.23 billion by 2026 growing at a CAGR of 14.0% during the forecast period. Neurostimulation devices are implantable, programmable medical devices that deliver electrical stimulation to specific parts of the patient's brain, spinal cord or peripheral nervous system to help treat various conditions, including chronic pain, movement disorders, epilepsy and Parkinson's disease.

Some of the key factors driving the market are growing geriatric population, the introduction of technologically advanced products, and increasing incidence of chronic diseases. However, adverse effects and risks associated with neurostimulation devices and stringent regulations regarding product approval are restraining market growth.

Based on the application, the pain management segment is likely to have huge demand due to the high prevalence of chronic pain disorders and growing product usage for pain management on account of their high therapeutic value.

The key vendors mentioned are Medtronic, Inc., Boston Scientific Corporation, ST. Jude Medical, Inc., Cyberonics, Inc., Nevro Corporation, Neurosigma, Inc., Neuropace, Inc., Biocontrol Medical, Synapse Biomedical, Inc., and Neuronetics, Inc.

Types Covered:
  • External neurostimulation Devices
  • Implantable neurostimulation Devices
Products Covered:
  • Vagus Nerve Stimulation Devices
  • Transcutaneous Electrical Nerve Stimulation
  • Spinal Cord Stimulation (SCS) Devices
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
  • Deep Brain Stimulation (DBS) Devices
  • Hypoglossal Nerve Stimulation
  • Auditory Brainstem Implant
  • Other Products
Technologies Covered:
  • Internal Neuromodulation
  • External Neuromodulation (Non-Invasive)
Applications Covered:
  • Epilepsy
  • Dystonia
  • Pain Management
  • Parkinson's Disease
  • Essential Tremor
  • Chronic Pain Management
  • Depression
  • Refractory Epilepsy
  • Gastroparesis
  • Obsessive Compulsive Disorder(OCD)
  • Tremors
  • Alzheimer’s ischemia
  • Urinary and Fecal Incontinence
  • Treatment Resistant Depression(TRD)
  • Other Applications
End Users Covered:
  • Cognitive Care Centers
  • Hospitals/Clinics
  • Scientific Research Institutes
  • Other End Users
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period.

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Biocontrol Medical
  • Cyberonics, Inc.
  • Medtronic, Inc.
  • Neuronetics, Inc.
  • Neuropace, Inc.
  • Neurosigma, Inc.
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Neurostimulation Devices Market, By Type
5.1 Introduction
5.2 External Neurostimulation Devices
5.3 Implantable Neurostimulation Devices

6 Global Neurostimulation Devices Market, By Product
6.1 Introduction
6.2 Vagus Nerve Stimulation Devices
6.3 Transcutaneous Electrical Nerve Stimulation
6.4 Spinal Cord Stimulation (SCS) Devices
6.5 Sacral Nerve Stimulation
6.6 Gastric Electrical Stimulation
6.7 Deep Brain Stimulation (DBS) Devices
6.8 Hypoglossal Nerve Stimulation
6.9 Auditory Brainstem Implant
6.10 Other Products

7 Global Neurostimulation Devices Market, By Technology
7.1 Introduction
7.2 Internal Neuromodulation
7.3 External Neuromodulation (Non-Invasive)

8 Global Neurostimulation Devices Market, By Application
8.1 Introduction
8.2 Epilepsy
8.3 Dystonia
8.4 Pain Management
8.5 Parkinson's Disease
8.6 Essential Tremor
8.7 Chronic Pain Management
8.8 Depression
8.9 Refractory Epilepsy
8.10 Gastroparesis
8.11 Obsessive Compulsive Disorder(OCD)
8.12 Tremors
8.13 Alzheimer’s ischemia
8.14 Urinary and Fecal Incontinence
8.15 Treatment Resistant Depression(TRD)
8.16 Other Applications

9 Global Neurostimulation Devices Market, By End User
9.1 Introduction
9.2 Cognitive Care Centers
9.3 Hospitals/Clinics
9.5 Scientific Research Institutes
9.6 Other End Users

10 Global Neurostimulation Devices Market, By Geography
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia Pacific
10.5 South America
10.6 Middle East & Africa

11 Strategic Benchmarking

12 Vendors Landscape
12.1 Medtronic, Inc.
12.2 Boston Scientific Corporation
12.3 ST. Jude Medical, Inc.
12.4 Cyberonics, Inc.
12.5 Nevro Corporation
12.6 Neurosigma, Inc.
12.7 Neuropace, Inc.
12.8 Biocontrol Medical
12.9 Synapse Biomedical, Inc.
12.10 Neuronetics, Inc.

List of Data Tables
Table 1 Global Neurostimulation Devices Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Neurostimulation Devices Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Neurostimulation Devices Market Outlook, By External Neurostimulation Devices (2016-2026) ($MN)
Table 4 Global Neurostimulation Devices Market Outlook, By Implantable Neurostimulation Devices (2016-2026) ($MN)
Table 5 Global Neurostimulation Devices Market Outlook, By Product (2016-2026) ($MN)
Table 6 Global Neurostimulation Devices Market Outlook, By Vagus Nerve Stimulation devices (2016-2026) ($MN)
Table 7 Global Neurostimulation Devices Market Outlook, By Transcutaneous Electrical Nerve Stimulation (2016-2026) ($MN)
Table 8 Global Neurostimulation Devices Market Outlook, By Spinal Cord Stimulation (SCS) devices (2016-2026) ($MN)
Table 9 Global Neurostimulation Devices Market Outlook, By Sacral Nerve Stimulation (2016-2026) ($MN)
Table 10 Global Neurostimulation Devices Market Outlook, By Gastric Electrical Stimulation (2016-2026) ($MN)
Table 11 Global Neurostimulation Devices Market Outlook, By Deep Brain Stimulation (DBS) devices (2016-2026) ($MN)
Table 12 Global Neurostimulation Devices Market Outlook, By Hypoglossal Nerve Stimulation (2016-2026) ($MN)
Table 13 Global Neurostimulation Devices Market Outlook, By Auditory Brainstem Implant (2016-2026) ($MN)
Table 14 Global Neurostimulation Devices Market Outlook, By Other Products (2016-2026) ($MN)
Table 15 Global Neurostimulation Devices Market Outlook, By Technology (2016-2026) ($MN)
Table 16 Global Neurostimulation Devices Market Outlook, By Internal Neuromodulation (2016-2026) ($MN)
Table 17 Global Neurostimulation Devices Market Outlook, By External Neuromodulation (Non-Invasive) (2016-2026) ($MN)
Table 18 Global Neurostimulation Devices Market Outlook, By Application (2016-2026) ($MN)
Table 19 Global Neurostimulation Devices Market Outlook, By Epilepsy (2016-2026) ($MN)
Table 20 Global Neurostimulation Devices Market Outlook, By Dystonia (2016-2026) ($MN)
Table 21 Global Neurostimulation Devices Market Outlook, By Pain Management (2016-2026) ($MN)
Table 22 Global Neurostimulation Devices Market Outlook, By Parkinson's Disease (2016-2026) ($MN)
Table 23 Global Neurostimulation Devices Market Outlook, By Essential Tremor (2016-2026) ($MN)
Table 24 Global Neurostimulation Devices Market Outlook, By Chronic Pain Management (2016-2026) ($MN)
Table 25 Global Neurostimulation Devices Market Outlook, By Depression (2016-2026) ($MN)
Table 26 Global Neurostimulation Devices Market Outlook, By Refractory Epilepsy (2016-2026) ($MN)
Table 27 Global Neurostimulation Devices Market Outlook, By Gastroparesis (2016-2026) ($MN)
Table 28 Global Neurostimulation Devices Market Outlook, By Obsessive Compulsive Disorder(OCD) (2016-2026) ($MN)
Table 29 Global Neurostimulation Devices Market Outlook, By Tremors (2016-2026) ($MN)
Table 30 Global Neurostimulation Devices Market Outlook, By Alzheimer’s ischemia (2016-2026) ($MN)
Table 31 Global Neurostimulation Devices Market Outlook, By Urinary and Fecal Incontinence (2016-2026) ($MN)
Table 32 Global Neurostimulation Devices Market Outlook, By Treatment Resistant Depression(TRD) (2016-2026) ($MN)
Table 33 Global Neurostimulation Devices Market Outlook, By Other Applications (2016-2026) ($MN)
Table 34 Global Neurostimulation Devices Market Outlook, By End User (2016-2026) ($MN)
Table 35 Global Neurostimulation Devices Market Outlook, By Cognitive Care Centers (2016-2026) ($MN)
Table 36 Global Neurostimulation Devices Market Outlook, By Hospitals/Clinics (2016-2026) ($MN)
Table 37 Global Neurostimulation Devices Market Outlook, By Scientific Research Institutes (2016-2026) ($MN)
Table 38 Global Neurostimulation Devices Market Outlook, By Other End Users (2016-2026) ($MN)
Table 39 North America Neurostimulation Devices Market Outlook, By Type (2016-2026) ($MN)
Table 40 North America Neurostimulation Devices Market Outlook, By Product (2016-2026) ($MN)
Table 41 North America Neurostimulation Devices Market Outlook, By Technology (2016-2026) ($MN)
Table 42 North America Neurostimulation Devices Market Outlook, By Application (2016-2026) ($MN)
Table 43 North America Neurostimulation Devices Market Outlook, By End User (2016-2026) ($MN)
Table 44 Europe Neurostimulation Devices Market Outlook, By Type (2016-2026) ($MN)
Table 45 Europe Neurostimulation Devices Market Outlook, By Product (2016-2026) ($MN)
Table 46 Europe Neurostimulation Devices Market Outlook, By Technology (2016-2026) ($MN)
Table 47 Europe Neurostimulation Devices Market Outlook, By Application (2016-2026) ($MN)
Table 48 Europe Neurostimulation Devices Market Outlook, By End User (2016-2026) ($MN)
Table 49 Asia Pacific Neurostimulation Devices Market Outlook, By Type (2016-2026) ($MN)
Table 50 Asia Pacific Neurostimulation Devices Market Outlook, By Product (2016-2026) ($MN)
Table 51 Asia Pacific Neurostimulation Devices Market Outlook, By Technology (2016-2026) ($MN)
Table 52 Asia Pacific Neurostimulation Devices Market Outlook, By Application (2016-2026) ($MN)
Table 53 Asia Pacific Neurostimulation Devices Market Outlook, By End User (2016-2026) ($MN)
Table 54 South America Neurostimulation Devices Market Outlook, By Type (2016-2026) ($MN)
Table 55 South America Neurostimulation Devices Market Outlook, By Product (2016-2026) ($MN)
Table 56 South America Neurostimulation Devices Market Outlook, By Technology (2016-2026) ($MN)
Table 57 South America Neurostimulation Devices Market Outlook, By Application (2016-2026) ($MN)
Table 58 South America Neurostimulation Devices Market Outlook, By End User (2016-2026) ($MN)
Table 59 Middle East & Africa Neurostimulation Devices Market Outlook, By Type (2016-2026) ($MN)
Table 60 Middle East & Africa Neurostimulation Devices Market Outlook, By Product (2016-2026) ($MN)
Table 61 Middle East & Africa Neurostimulation Devices Market Outlook, By Technology (2016-2026) ($MN)
Table 62 Middle East & Africa Neurostimulation Devices Market Outlook, By Application (2016-2026) ($MN)
Table 63 Middle East & Africa Neurostimulation Devices Market Outlook, By End User (2016-2026) ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Medtronic, Inc.
  • Boston Scientific Corporation
  • ST. Jude Medical, Inc.
  • Cyberonics, Inc.
  • Nevro Corporation
  • Neurosigma, Inc.
  • Neuropace, Inc.
  • Biocontrol Medical
  • Synapse Biomedical, Inc.
  • Neuronetics, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll